MBI collaborates with IFOM in the fight against cancer

MBI-IFOM partnership

In May 2014, a new partnership was formed between the Mechanobiology Institute (MBI), Singapore, and the FIRC Institute of Molecular Oncology (IFOM), Italy, that will see the establishment of a ‘Joint Research Laboratory’, to be headed by Prof GV Shivashankar, deputy-director of the MBI.


MBI deputy-director, Prof GV Shivashankar, will head the new joint research laboratory.

This partnership aims to develop a multi- disciplinary approach to cancer research, where traditional biology is further enhanced by technologies and methods developed in fields such as mathematics, physics, engineering and computational biology. The Joint Research Laboratory will focus on understanding the molecular mechanisms that drive tumor formation and development.

The Joint Research Lab will enable a strong multidisciplinary approach to understanding the mechanobiological basis of cancer by bringing together the Mechanobiology Institute, Singapore and FIRC institute of Molecular Oncology (IFOM) –
two of the world’s leading institutes.”

– Prof GV Shivashankar

What this means for cancer research

Cancer continues to be a major cause of death in developed countries. Although lifestyle choices such as smoking or excessive exposure to the sun raise the risk of acquiring the disease, even the healthiest individuals are not immune. This is because cancer originates at a level largely beyond our reach, within individual cells, and following the gradual dysregulation of important cellular and molecular processes. When approaching cancer from the perspective of a single cell, a highly complex scene lies before the researcher. Hundreds of molecular pathways are intertwined like a spider’s web of protein function and regulation. One protein can control the function of several others, culminating in measurable cellular events, such as cell motility.

multiple cells merge

Recent work from Prof Shivashankar’s lab.

At the center of this web is the cell’s DNA; the molecule from which all proteins are made. Although healthy cells possess mechanisms to detect and repair damaged DNA, this is often lost in cancer cells. The production of proteins that do not function correctly, if at all, can lead to a cascade of molecular events that results in erratic cell growth, a shift in cellular metabolism or the ability of a cell to avoid death. Adding to this issue is the tendency for cancer cells to produce proteins at levels above or below that of a healthy cell.

With traditional cell biology continuing to make significant ground towards deciphering the cause and effect of perturbations in protein function and level, the integration of techniques from other fields is becoming increasingly relevant. This will be further encouraged by the Joint Research Laboratory, which will focus on establishing how mechanical forces placed on cancer cells, such as stretch or compression, determine their ability to read DNA, and produce proteins.

Recent work from the Shivashankar lab has established crucial links between cell shape, nuclear dynamics, and protein production. This work will be further explored by the Joint Research Laboratory, which will focus particularly on the relationship between mechanical and chemical signaling in protein production and cancer development.

IFOM_100dpiRGBCytokines, which are small proteins that function as chemical signals, are known to promote the production of proteins that degrade or restore the extracellular matrix; which is a component of the body that provides structural and biochemical support to many cell types. Degradation of the extracellular matrix is required for cellular invasion, and it is therefore closely linked to the onset of cancer. The primary focus of the Joint Research Laboratory will be to establish how geometric constraints within tissues, and upon individual cells, affect the cellular response to cytokines.

Through the MBI-IFOM partnership, further studies into the mechanisms that control nuclear dynamics and mbiLogo_whtprotein synthesis will be possible. Mathematical modelling and computer simulations will help predict the effect of mechanical stress on protein synthesis while cells will continue to be grown on surfaces designed to mimic those found in the body, such as bone, muscle or cartilage. By adopting a multidisciplinary approach to its research, the Joint Research Laboratory will be well placed to assess the effect of stretching or compressive forces on regulating cancer specific signaling pathways and protein synthesis.

2014IFOMMBIpressRelCapLearn more

Founded in 1998 by FIRC, the Institute of Molecular Oncology (IFOM) is a cancer research institute focused on the study of cancer formation and development at molecular level, with a view to a rapid transfer of results from bench to bedside. Find out more.

Instituted in 2009, the Mechanobiology Institute, Singapore (MBI) was created to identify, measure and describe how the forces for motility and morphogenesis are expressed at the molecular, cellular and tissue level. Read more about MBI.

Learn more about Prof GV Shivashankar’s research.

Download press release (PDF).


A protein that senses the mechanical vibrations of cells and controls cellular plasticity is identified. A step forward in the understanding of metastasis and stem cells.

ATR Mediates a Checkpoint at the Nuclear Envelope in Response to Mechanical Stress.
Kumar A, Mazzanti M, Mistrik M, Kosar M, Beznoussenko GV, Mironov AA, Garrè M, Parazzoli D, Shivashankar GV, Scita G, Bartek J, Foiani M. Cell. 2014 Jul 31;158(3):633-46. doi: 10.1016/j.cell.2014.05.046.

The C-terminal domain (CTD) in linker histones antagonizes anti-apoptotic proteins to modulate apoptotic outcomes at the mitochondrion. Garg M, Ramdas N, Vijayalakshmi M, Shivashankar GV, Sarin A. Cell Death Dis. 2014 Feb 13;5:e1058. doi: 10.1038/cddis.2014.20.

In this interdisciplinary research effort, conducted by IFOM and the University of Milan, in collaboration with the National University of Singapore and the Danish Cancer Society Research Center in Copenhagen, has identified the ATR protein, known for its role as DNA defender and tumor suppressor, as the engine of cellular plasticity. This completely unexpected role has important implications for the understanding of metastasis and stem cells. The discovery, published in Cell, was made in the IFOM laboratories in Milan by combining advanced microscopy with mechanical engineering and electrophysiology techniques.

Learn more about on-going research at IFOM.

Find out more about research at MBI.